The expanding role of GLP-1 therapies in new treatment pathways

Join us for an upcoming webinar to explore the expanding role of GLP-1 therapies beyond diabetes and weight management. CDE and Nurse Practitioner Peta Tauchmann will review emerging evidence supporting new indications for GLP-1 agents, including their potential applications in cardiovascular and renal disease. Peta brings extensive clinical, academic and leadership experience to her work and is a long-standing contributor to the diabetes education community.